carbachol has been researched along with Alzheimer Disease in 46 studies
Carbachol: A slowly hydrolyzed CHOLINERGIC AGONIST that acts at both MUSCARINIC RECEPTORS and NICOTINIC RECEPTORS.
Alzheimer Disease: A degenerative disease of the BRAIN characterized by the insidious onset of DEMENTIA. Impairment of MEMORY, judgment, attention span, and problem solving skills are followed by severe APRAXIAS and a global loss of cognitive abilities. The condition primarily occurs after age 60, and is marked pathologically by severe cortical atrophy and the triad of SENILE PLAQUES; NEUROFIBRILLARY TANGLES; and NEUROPIL THREADS. (From Adams et al., Principles of Neurology, 6th ed, pp1049-57)
| Excerpt | Relevance | Reference |
|---|---|---|
| "For patients with Alzheimer's disease, no correlation was obtained between age and S." | 5.28 | [Changes in DNA synthesis in lymphocytes induced by carbachol via muscarinic acetylcholine receptor in relation to aging and Alzheimer's disease in females]. ( Furukawa, Y, 1992) |
| " Young males showed greater responsiveness to both drugs than young females, this being reflected in higher maxima of the dose-response curves obtained for the males." | 5.27 | The responsiveness of human eccrine sweat glands to choline and carbachol. Application to the study of peripheral cholinergic functioning in Alzheimer-type dementia. ( Bradshaw, CM; Lamb, K; Szabadi, E, 1983) |
| "The relative proportion of super-high, high and low affinity agonist binding sites was measured in the hippocampus from individuals with dementia of the Alzheimer type (AD/SDAT), mixed (AD-MID) type and controls, using labelled quinuclidinyl benzilate ([3H]QNB) competing with unlabelled carbachol." | 3.67 | Muscarinic receptor subtypes in hippocampus in Alzheimer's disease and mixed dementia type. ( Alafuzoff, I; Nordberg, A; Winblad, B, 1986) |
| "Carbachol was a chemoattractant for microglia and decreased their phagocytic activity." | 1.43 | The subpopulation of microglia expressing functional muscarinic acetylcholine receptors expands in stroke and Alzheimer's disease. ( Endres, M; Kettenmann, H; Kronenberg, G; Matyash, V; Meier, MA; Pannell, M; Prinz, V; Szulzewsky, F; Waiczies, S; Wolf, SA, 2016) |
| "Neurochemical alterations in Alzheimer's disease (AD) include cholinergic neuronal loss in the nucleus basalis of Meynert (nbM) and a decrease in densities of the M2 muscarinic receptor subtype in areas related to learning and memory." | 1.43 | Activity of muscarinic, galanin and cannabinoid receptors in the prodromal and advanced stages in the triple transgenic mice model of Alzheimer's disease. ( Giménez-Llort, L; LaFerla, FM; Lombardero, L; Manuel, I; Rodríguez-Puertas, R, 2016) |
| "The study of late-onset/age-related Alzheimer's disease (AD)(sporadic AD, 95% of AD cases) has been hampered by a paucity of animal models." | 1.42 | Characterization of Aldh2 (-/-) mice as an age-related model of cognitive impairment and Alzheimer's disease. ( Andrew, RD; Bennett, BM; D'Souza, Y; Elharram, A; Soon-Shiong, R, 2015) |
| "Our previous studies indicated that Alzheimer's disease (AD) related amyloid beta peptide (Abeta) significantly altered muscarinic cholinergic receptor (mChR) signaling on the level of G protein regulated phospholipase C (PLC) leading to the lower formation of inositol-1,4,5-triphosphate (IP3) and diacylglycerol (DAG)." | 1.33 | Alzheimer's disease related peptides affected cholinergic receptor mediated poly(ADP-ribose) polymerase activity in the hippocampus. ( Adamczyk, A; Jeśko, H; Strosznajder, RP, 2005) |
| "The senile plaque in Alzheimer's disease (AD) consists mainly of the amyloid beta-peptide (A beta) derived from a larger beta-amyloid precursor protein (betaAPP)." | 1.30 | The effect of tacrine and leupeptin on the secretion of the beta-amyloid precursor protein in HeLa cells. ( Farlow, MR; Lahiri, DK; Nall, C; Sambamurti, K, 1997) |
| "The effects of Alzheimer's disease (AD) on [35S]GTP gamma S binding to G proteins was examined in postmortem cerebrocortex." | 1.29 | Receptor-mediated activation of G proteins is reduced in postmortem brains from Alzheimer's disease patients. ( Friedman, E; Wang, HY, 1994) |
| "For patients with Alzheimer's disease, no correlation was obtained between age and S." | 1.28 | [Changes in DNA synthesis in lymphocytes induced by carbachol via muscarinic acetylcholine receptor in relation to aging and Alzheimer's disease in females]. ( Furukawa, Y, 1992) |
| " Young males showed greater responsiveness to both drugs than young females, this being reflected in higher maxima of the dose-response curves obtained for the males." | 1.27 | The responsiveness of human eccrine sweat glands to choline and carbachol. Application to the study of peripheral cholinergic functioning in Alzheimer-type dementia. ( Bradshaw, CM; Lamb, K; Szabadi, E, 1983) |
| "Tacrine was a weak competitor of [3H]phenylisopropyladenosine ([3H]L-PIA) binding in brain membranes." | 1.27 | Blockade of a cardiac K+ channel by tacrine: interactions with muscarinic and adenosine receptors. ( Freeman, SE; Lau, WM; Szilagyi, M, 1988) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (15.22) | 18.7374 |
| 1990's | 21 (45.65) | 18.2507 |
| 2000's | 11 (23.91) | 29.6817 |
| 2010's | 7 (15.22) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dunbar, PG | 1 |
| Durant, GJ | 1 |
| Rho, T | 1 |
| Ojo, B | 1 |
| Huzl, JJ | 1 |
| Smith, DA | 1 |
| el-Assadi, AA | 1 |
| Sbeih, S | 1 |
| Ngur, DO | 1 |
| Periyasamy, S | 1 |
| Bromidge, SM | 1 |
| Brown, F | 1 |
| Cassidy, F | 1 |
| Clark, MS | 1 |
| Dabbs, S | 1 |
| Hadley, MS | 1 |
| Hawkins, J | 1 |
| Loudon, JM | 1 |
| Naylor, CB | 1 |
| Orlek, BS | 1 |
| Riley, GJ | 1 |
| Honarnejad, K | 2 |
| Kirsch, AK | 1 |
| Daschner, A | 2 |
| Szybinska, A | 2 |
| Kuznicki, J | 2 |
| Herms, J | 2 |
| Giese, A | 1 |
| Zall, A | 1 |
| Schmidt, B | 1 |
| Pannell, M | 1 |
| Meier, MA | 1 |
| Szulzewsky, F | 1 |
| Matyash, V | 1 |
| Endres, M | 1 |
| Kronenberg, G | 1 |
| Prinz, V | 1 |
| Waiczies, S | 1 |
| Wolf, SA | 1 |
| Kettenmann, H | 1 |
| D'Souza, Y | 1 |
| Elharram, A | 1 |
| Soon-Shiong, R | 1 |
| Andrew, RD | 1 |
| Bennett, BM | 1 |
| Manuel, I | 1 |
| Lombardero, L | 1 |
| LaFerla, FM | 1 |
| Giménez-Llort, L | 1 |
| Rodríguez-Puertas, R | 1 |
| Akay, M | 2 |
| Wang, K | 2 |
| Akay, YM | 2 |
| Dragomir, A | 2 |
| Wu, J | 2 |
| Hicks, DA | 1 |
| Makova, NZ | 1 |
| Nalivaeva, NN | 1 |
| Turner, AJ | 1 |
| Muma, NA | 1 |
| Mariyappa, R | 1 |
| Williams, K | 1 |
| Lee, JM | 3 |
| Zhong, P | 1 |
| Gu, Z | 1 |
| Wang, X | 1 |
| Jiang, H | 1 |
| Feng, J | 1 |
| Yan, Z | 1 |
| Shiozaki, K | 1 |
| Iseki, E | 1 |
| Magdesian, MH | 1 |
| Nery, AA | 1 |
| Martins, AH | 1 |
| Juliano, MA | 1 |
| Juliano, L | 1 |
| Ulrich, H | 1 |
| Ferreira, ST | 1 |
| Adamczyk, A | 1 |
| Jeśko, H | 1 |
| Strosznajder, RP | 1 |
| Schliebs, R | 1 |
| Heidel, K | 1 |
| Apelt, J | 1 |
| Gniezdzinska, M | 1 |
| Kirazov, L | 1 |
| Szutowicz, A | 1 |
| Warren, NM | 1 |
| Piggott, MA | 1 |
| Lees, AJ | 1 |
| Perry, EK | 2 |
| Burn, DJ | 1 |
| Lamb, K | 1 |
| Bradshaw, CM | 1 |
| Szabadi, E | 1 |
| Alder, JT | 1 |
| Chessell, IP | 2 |
| Bowen, DM | 1 |
| Ladner, CJ | 2 |
| Celesia, GG | 1 |
| Magnuson, DJ | 1 |
| Ferrari-DiLeo, G | 2 |
| Mash, DC | 3 |
| Flynn, DD | 4 |
| Wolf, BA | 1 |
| Wertkin, AM | 1 |
| Jolly, YC | 1 |
| Yasuda, RP | 1 |
| Wolfe, BB | 1 |
| Konrad, RJ | 1 |
| Manning, D | 1 |
| Ravi, S | 1 |
| Williamson, JR | 1 |
| Lee, VM | 1 |
| Cutler, R | 1 |
| Joseph, JA | 1 |
| Yamagami, K | 1 |
| Villalobos-Molina, R | 1 |
| Roth, GS | 1 |
| Wang, HY | 1 |
| Friedman, E | 1 |
| Warpman, U | 1 |
| Alafuzoff, I | 2 |
| Nordberg, A | 2 |
| Humphrey, PP | 1 |
| Chessell, JP | 1 |
| Lahiri, DK | 1 |
| Farlow, MR | 1 |
| Sambamurti, K | 1 |
| Nall, C | 1 |
| DeLapp, N | 1 |
| Wu, S | 1 |
| Belagaje, R | 1 |
| Johnstone, E | 1 |
| Little, S | 1 |
| Shannon, H | 1 |
| Bymaster, F | 1 |
| Calligaro, D | 1 |
| Mitch, C | 1 |
| Whitesitt, C | 1 |
| Ward, J | 1 |
| Sheardown, M | 1 |
| Fink-Jensen, A | 1 |
| Jeppesen, L | 1 |
| Thomsen, C | 1 |
| Sauerberg, P | 1 |
| Fowler, CJ | 1 |
| Tiger, G | 1 |
| Forlenza, OV | 1 |
| Spink, JM | 1 |
| Dayanandan, R | 1 |
| Anderton, BH | 1 |
| Olesen, OF | 1 |
| Lovestone, S | 1 |
| Pettit, DL | 1 |
| Shao, Z | 1 |
| Yakel, JL | 1 |
| Cedazo-Mínguez, A | 1 |
| Hamker, U | 1 |
| Meske, V | 1 |
| Veh, RW | 1 |
| Hellweg, R | 1 |
| Jacobi, C | 1 |
| Albert, F | 1 |
| Cowburn, RF | 1 |
| Ohm, TG | 1 |
| Nitsch, RM | 1 |
| Slack, BE | 1 |
| Wurtman, RJ | 1 |
| Growdon, JH | 1 |
| Furukawa, Y | 1 |
| Weinstein, DA | 1 |
| Fulop, T | 1 |
| Kekessy, D | 1 |
| Foris, G | 1 |
| Smith, CJ | 1 |
| Court, JA | 1 |
| Perry, RH | 1 |
| Araujo, DM | 2 |
| Lapchak, PA | 2 |
| Collier, B | 1 |
| Quirion, R | 2 |
| Rinne, JO | 1 |
| Lönnberg, P | 1 |
| Marjamäki, P | 1 |
| Rinne, UK | 1 |
| Freeman, SE | 1 |
| Lau, WM | 1 |
| Szilagyi, M | 1 |
| Robitaille, Y | 1 |
| Gauthier, S | 1 |
| Winblad, B | 1 |
1 review available for carbachol and Alzheimer Disease
| Article | Year |
|---|---|
N-[3H]methylcarbamylcholine binding sites in the rat and human brain: relationship to functional nicotinic autoreceptors and alterations in Alzheimer's disease.
Topics: Alzheimer Disease; Animals; Brain Chemistry; Carbachol; Humans; Radioligand Assay; Rats; Receptors, | 1989 |
45 other studies available for carbachol and Alzheimer Disease
| Article | Year |
|---|---|
Design, synthesis, and neurochemical evaluation of 2-amino-5-(alkoxycarbonyl)-3,4,5,6-tetrahydropyridines and 2-amino-5-(alkoxycarbonyl)-1,4,5,6-tetrahydropyrimidines as M1 muscarinic receptor agonists.
Topics: Alzheimer Disease; Animals; Cerebral Cortex; Drug Design; Humans; In Vitro Techniques; Indicators an | 1994 |
Design of [R-(Z)]-(+)-alpha-(methoxyimino)-1-azabicyclo[2.2.2]octane-3-acetonitri le (SB 202026), a functionally selective azabicyclic muscarinic M1 agonist incorporating the N-methoxy imidoyl nitrile group as a novel ester bioisostere.
Topics: Alzheimer Disease; Animals; Binding Sites; Blood Pressure; Brain; CHO Cells; Cricetinae; Electroence | 1997 |
FRET-based calcium imaging: a tool for high-throughput/content phenotypic drug screening in Alzheimer disease.
Topics: Alzheimer Disease; Bacterial Proteins; Calcium Signaling; Calmodulin-Binding Proteins; Carbachol; Dr | 2013 |
Development and implementation of a high-throughput compound screening assay for targeting disrupted ER calcium homeostasis in Alzheimer's disease.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Calcium; Calcium Channels; Carbachol; Cell Line; Drug Disc | 2013 |
The subpopulation of microglia expressing functional muscarinic acetylcholine receptors expands in stroke and Alzheimer's disease.
Topics: Alzheimer Disease; Animals; Brain; Carbachol; Disease Models, Animal; Female; Glioma; Macrophages; M | 2016 |
Characterization of Aldh2 (-/-) mice as an age-related model of cognitive impairment and Alzheimer's disease.
Topics: Aging; Aldehyde Dehydrogenase; Aldehyde Dehydrogenase, Mitochondrial; Aldehydes; Alzheimer Disease; | 2015 |
Activity of muscarinic, galanin and cannabinoid receptors in the prodromal and advanced stages in the triple transgenic mice model of Alzheimer's disease.
Topics: Aging; Alzheimer Disease; Animals; Autoradiography; Brain; Carbachol; Disease Models, Animal; Diseas | 2016 |
Nonlinear dynamical analysis of carbachol induced hippocampal oscillations in mice.
Topics: Age Factors; Alzheimer Disease; Animals; Carbachol; Cholinergic Agonists; Disease Models, Animal; El | 2009 |
Decoding state transitions in hippocampal oscillatory activity in mice.
Topics: Alzheimer Disease; Animals; Carbachol; Disease Models, Animal; Hippocampus; Markov Chains; Mice; Mic | 2010 |
Characterisation of acetylcholinesterase release from neuronal cells.
Topics: Acetylcholinesterase; Alzheimer Disease; Animals; Atropine; Butyrylcholinesterase; Carbachol; Cell L | 2013 |
Differences in regional and subcellular localization of G(q/11) and RGS4 protein levels in Alzheimer's disease: correlation with muscarinic M1 receptor binding parameters.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Autopsy; Brain; Brain Chemistry; Carbachol; Case-Control | 2003 |
Impaired modulation of GABAergic transmission by muscarinic receptors in a mouse transgenic model of Alzheimer's disease.
Topics: Action Potentials; Alzheimer Disease; Amyloid beta-Protein Precursor; Animals; Carbachol; Disease Mo | 2003 |
Decrease in GTP-sensitive high affinity agonist binding of muscarinic acetylcholine receptors in autopsied brains of dementia with Lewy bodies and Alzheimer's disease.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Analysis of Variance; Autopsy; Binding, Competitive; Bra | 2004 |
Peptide blockers of the inhibition of neuronal nicotinic acetylcholine receptors by amyloid beta.
Topics: Alzheimer Disease; Amino Acid Sequence; Amyloid beta-Peptides; Animals; Carbachol; Cholinergic Agoni | 2005 |
Alzheimer's disease related peptides affected cholinergic receptor mediated poly(ADP-ribose) polymerase activity in the hippocampus.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Calcium Channel Blockers; Calcium Channels; Carba | 2005 |
Interaction of interleukin-1beta with muscarinic acetylcholine receptor-mediated signaling cascade in cholinergically differentiated SH-SY5Y cells.
Topics: Acetylcholinesterase; Alzheimer Disease; Carbachol; Cholinergic Agonists; Dose-Response Relationship | 2006 |
Intact coupling of M1 receptors and preserved M2 and M4 receptors in the cortex in progressive supranuclear palsy: contrast with other dementias.
Topics: Alzheimer Disease; Atropine; Autoradiography; Carbachol; Cerebral Cortex; Dementia; Humans; Lewy Bod | 2008 |
The responsiveness of human eccrine sweat glands to choline and carbachol. Application to the study of peripheral cholinergic functioning in Alzheimer-type dementia.
Topics: Adult; Aged; Aging; Alzheimer Disease; Carbachol; Choline; Dementia; Dose-Response Relationship, Dru | 1983 |
A neurochemical approach for studying response to acetylcholine in Alzheimer's disease.
Topics: Acetylcholine; Alzheimer Disease; Animals; Biomarkers; Carbachol; Cholinergic Agents; Frontal Lobe; | 1995 |
Regional alterations in M1 muscarinic receptor-G protein coupling in Alzheimer's disease.
Topics: Aged; Alzheimer Disease; Binding Sites; Brain; Carbachol; Frontal Lobe; GTP-Binding Proteins; Humans | 1995 |
Attenuation of muscarinic receptor-G-protein interaction in Alzheimer disease.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Carbachol; Cerebral Cortex; Choline O-Acetyltransferase; | 1995 |
Muscarinic regulation of Alzheimer's disease amyloid precursor protein secretion and amyloid beta-protein production in human neuronal NT2N cells.
Topics: Alzheimer Disease; Amyloid; Amyloid beta-Peptides; Carbachol; Enzyme Activation; Humans; Neurons; Pr | 1995 |
Area specific alterations in muscarinic stimulated low Km GTPase activity in aging and Alzheimer's disease: implications for altered signal transduction.
Topics: Aged; Aged, 80 and over; Aging; Alzheimer Disease; Carbachol; Enzyme Activation; GTP Phosphohydrolas | 1994 |
Receptor-mediated activation of G proteins is reduced in postmortem brains from Alzheimer's disease patients.
Topics: Aged; Alzheimer Disease; Biotransformation; Brain Chemistry; Carbachol; Female; GTP-Binding Proteins | 1994 |
Diminished muscarinic receptor-stimulated [3H]-PIP2 hydrolysis in Alzheimer's disease.
Topics: Aged; Alzheimer Disease; Binding, Competitive; Carbachol; Cell Membrane; Choline O-Acetyltransferase | 1993 |
Coupling of muscarinic receptors to GTP proteins in postmortem human brain--alterations in Alzheimer's disease.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Autopsy; Binding, Competitive; Brain; Carbachol; Female; | 1993 |
Nicotinic and muscarinic receptor-evoked depolarizations recorded from a novel cortical brain slice preparation.
Topics: Alzheimer Disease; Animals; Carbachol; Cerebral Cortex; Dimethylphenylpiperazinium Iodide; Dose-Resp | 1995 |
Acetylcholine receptor targets on cortical pyramidal neurones as targets for Alzheimer's therapy.
Topics: Alzheimer Disease; Autoradiography; Carbachol; Cerebral Cortex; Electrophysiology; Glycoproteins; Hu | 1996 |
The effect of tacrine and leupeptin on the secretion of the beta-amyloid precursor protein in HeLa cells.
Topics: Alzheimer Disease; Amyloid beta-Protein Precursor; Carbachol; Cholinesterase Inhibitors; Culture Med | 1997 |
Effects of the M1 agonist xanomeline on processing of human beta-amyloid precursor protein (FAD, Swedish mutant) transfected into Chinese hamster ovary-m1 cells.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Animals; Blotting, Western | 1998 |
The sulphydryl oxidizing reagent diamide affects phosphoinositide-mediated signal transduction: implications for the pathogenesis of Alzheimer's disease.
Topics: Alzheimer Disease; Animals; Blood Platelets; Brain; Calcium Signaling; Carbachol; Diamide; Dithiothr | 1998 |
Reduced high-affinity agonist binding at the M(1) muscarinic receptor in Alzheimer's disease brain: differential sensitivity to agonists and divalent cations.
Topics: Acetylcholine; Aged; Alzheimer Disease; Brain; Carbachol; Cations, Divalent; Chlorides; Edetic Acid; | 1999 |
Muscarinic agonists reduce tau phosphorylation in non-neuronal cells via GSK-3beta inhibition and in neurons.
Topics: Acetylcholine; Alzheimer Disease; Amyloid beta-Protein Precursor; Animals; Binding Sites; Calcium-Ca | 2000 |
beta-Amyloid(1-42) peptide directly modulates nicotinic receptors in the rat hippocampal slice.
Topics: Acetylcholine; Alzheimer Disease; Amyloid beta-Peptides; Animals; Carbachol; Cognition Disorders; Do | 2001 |
Regulation of apolipoprotein E secretion in rat primary hippocampal astrocyte cultures.
Topics: Alzheimer Disease; Animals; Animals, Newborn; Apolipoproteins E; Astrocytes; Bucladesine; Carbachol; | 2001 |
Release of Alzheimer amyloid precursor derivatives stimulated by activation of muscarinic acetylcholine receptors.
Topics: Alkaloids; Alzheimer Disease; Amyloid beta-Protein Precursor; Atropine; Blotting, Western; Brain Che | 1992 |
[Changes in DNA synthesis in lymphocytes induced by carbachol via muscarinic acetylcholine receptor in relation to aging and Alzheimer's disease in females].
Topics: Adult; Aged; Aging; Alzheimer Disease; Carbachol; Cells, Cultured; DNA; Female; Humans; Lymphocytes; | 1992 |
Loss of high-affinity agonist binding to M1 muscarinic receptors in Alzheimer's disease: implications for the failure of cholinergic replacement therapies.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Carbachol; Choline O-Acetyltransferase; Female; Frontal | 1991 |
Altered post-receptorial signal transduction mechanism under various stimulation in polymorphonuclear granulocytes of Alzheimer's disease.
Topics: Aged; Aged, 80 and over; Aging; Alzheimer Disease; Carbachol; Cyclic AMP; Cyclic GMP; Enkephalin, Me | 1990 |
Cholinergic nicotinic and muscarinic receptors in dementia of Alzheimer, Parkinson and Lewy body types.
Topics: Adult; Aged; Aged, 80 and over; Alzheimer Disease; Brain Chemistry; Carbachol; Choline O-Acetyltrans | 1990 |
Brain muscarinic receptor subtypes are differently affected in Alzheimer's disease and Parkinson's disease.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Brain; Carbachol; Choline O-Acetyltransferase; Cholinerg | 1989 |
Blockade of a cardiac K+ channel by tacrine: interactions with muscarinic and adenosine receptors.
Topics: Action Potentials; Adenosine; Alzheimer Disease; Aminoacridines; Animals; Carbachol; Guinea Pigs; He | 1988 |
Differential alteration of various cholinergic markers in cortical and subcortical regions of human brain in Alzheimer's disease.
Topics: Acetylcholine; Aged; Aged, 80 and over; Alzheimer Disease; Brain; Carbachol; Cerebral Cortex; Cholin | 1988 |
Characterization of L-[3H]nicotine binding in human cerebral cortex: comparison between Alzheimer's disease and the normal.
Topics: Adult; Aged; Aged, 80 and over; Aging; Alzheimer Disease; Animals; Carbachol; Cerebral Cortex; Choli | 1986 |
Muscarinic receptor subtypes in hippocampus in Alzheimer's disease and mixed dementia type.
Topics: Aged; Alzheimer Disease; Carbachol; Dementia; Female; Hippocampus; Humans; Male; Quinuclidinyl Benzi | 1986 |